Patents by Inventor Bruno Huet De Barochez

Bruno Huet De Barochez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microcapsules for the delayed, controlled release of perindopril
    Publication number: 20060165808
    Abstract: The present invention relates to A microcapsule composition allowing the delayed and controlled release of perindopril, or of a pharmaceutically acceptable salt thereof, for administration by the oral route.
    Type: Application
    Filed: June 24, 2003
    Publication date: July 27, 2006
    Inventors: Bruno Huet De Barochez, Patrick Wuthrich, Valerie Legrand, Catherine Castan, Remi Meyrueix
  • Core tablet for controlled release of gliclazide after oral administration
    Patent number: 6733782
    Abstract: The invention relates to a matrix tablet for the prolonged release of gliclazide which ensures continuous and consistent release of the active ingredient after administration by the oral route, the release being insensitive to variations in the pH of the dissolution medium.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: May 11, 2004
    Assignee: Les Laboratories Servier
    Inventors: Bruno Huet De Barochez, Patrick Wuthrich, Louis Martin
  • Pharmaceutical composition for the programmed release of dexfenfluramine
    Patent number: 5980952
    Abstract: A novel pharmaceutical composition allowing the programmed release of dexfenfluramine containing a water-soluble acid addition salt of dexfenfluramine on a mixture of minigranules, both rapid release and slow release minigranules, permits the attainment of two concentration peaks in the plasma of patients treated therewith.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: November 9, 1999
    Assignee: Adir Et Compagnie
    Inventors: Bruno Huet De Barochez, Claude Dauphant, Patrick Wuthrich
  • Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route
    Patent number: 5888542
    Abstract: The invention relates to a matrix tablet for the prolonged release of the sodium salt of tianeptine which ensures a continuous and uniform release of the active ingredient after administration by the oral route.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: March 30, 1999
    Assignee: Adir Et Compagnie
    Inventors: Bruno Huet de Barochez, Patrick Wuthrich